Article ; Online: Trimethoprim-sulfamethoxazole induced aseptic meningitis case report.
2023 Volume 102, Issue 1, Page(s) e32475
Abstract: Rationale: Drug-induced aseptic meningitis (DIAM) is an uncommon meningitis and trimethoprim with or without sulfamethoxazole is the most involved antibiotic. Although DIAM is easily treated with the discontinuation of the causative drug, the diagnosis ... ...
| Abstract | Rationale: Drug-induced aseptic meningitis (DIAM) is an uncommon meningitis and trimethoprim with or without sulfamethoxazole is the most involved antibiotic. Although DIAM is easily treated with the discontinuation of the causative drug, the diagnosis is a big challenge for physicians, as it remains a diagnosis of exclusion. Here, we present a case report of trimethoprim-sulfamethoxazole induced aseptic meningitis in a woman with acute osteomyelitis. Patient concerns: A 52-year-old woman was admitted to the hospital for septic shock and acute osteomyelitis of the right homerus. She was started on antibiotic therapy with oxacillin and daptomycin, then oxacillin was replaced with cotrimoxazole, due to its excellent tissue penetration, including bone tissue. During cotrimoxazole therapy, the patient developed a fluent aphasia with ideomotor apraxia and muscle hypertonus. Diagnosis and interventions: Having excluded infectious, epileptic and vascular causes of the acute neurologic syndrome of our patient, given the improvement and full recovery after discontinuation of cotrimoxazole, we hypothesized a DIAM. Outcomes: After discontinuation of cotrimoxazole, in 48 hours the patient had a full recovery. Lessons: Although DIAM can be easily managed with the withdrawal of the causative drug, it can be difficult to recognize if it is not included in the differential diagnosis. An antimicrobial stewardship program with a strict monitoring of patients by infectious disease specialists is essential, not only to optimize the appropriate use of antimicrobials, but also to improve patient outcomes and reduce the likelihood of adverse events. |
|---|---|
| MeSH term(s) | Female ; Humans ; Middle Aged ; Trimethoprim, Sulfamethoxazole Drug Combination/adverse effects ; Meningitis, Aseptic/chemically induced ; Meningitis, Aseptic/diagnosis ; Anti-Infective Agents ; Anti-Bacterial Agents/adverse effects ; Oxacillin/adverse effects |
| Chemical Substances | Trimethoprim, Sulfamethoxazole Drug Combination (8064-90-2) ; Anti-Infective Agents ; Anti-Bacterial Agents ; Oxacillin (UH95VD7V76) |
| Language | English |
| Publishing date | 2023-01-06 |
| Publishing country | United States |
| Document type | Case Reports ; Journal Article |
| ZDB-ID | 80184-7 |
| ISSN | 1536-5964 ; 0025-7974 |
| ISSN (online) | 1536-5964 |
| ISSN | 0025-7974 |
| DOI | 10.1097/MD.0000000000032475 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Ua VI Zs.171: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.